Anti-NLRP6/ AVR/ CLR11.4 monoclonal antibody

Anti-NLRP6/ AVR/ CLR11.4 antibody for FACS & in-vivo assay

Target products collectionGo to NLRP6/NLRP6 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP2400-Ab-1/ GM-Tg-hg-MP2400-Ab-2Anti-Human NLRP6 monoclonal antibodyHuman
GM-Tg-rg-MP2400-Ab-1/ GM-Tg-rg-MP2400-Ab-2Anti-Rat NLRP6 monoclonal antibodyRat
GM-Tg-mg-MP2400-Ab-1/ GM-Tg-mg-MP2400-Ab-2Anti-Mouse NLRP6 monoclonal antibodyMouse
GM-Tg-cynog-MP2400-Ab-1/ GM-Tg-cynog-MP2400-Ab-2Anti-Cynomolgus/ Rhesus macaque NLRP6 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP2400-Ab-1/ GM-Tg-felg-MP2400-Ab-2Anti-Feline NLRP6 monoclonal antibodyFeline
GM-Tg-cang-MP2400-Ab-1/ GM-Tg-cang-MP2400-Ab-2Anti-Canine NLRP6 monoclonal antibodyCanine
GM-Tg-bovg-MP2400-Ab-1/ GM-Tg-bovg-MP2400-Ab-2Anti-Bovine NLRP6 monoclonal antibodyBovine
GM-Tg-equg-MP2400-Ab-1/ GM-Tg-equg-MP2400-Ab-2Anti-Equine NLRP6 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP2400-Ab-1/ GM-Tg-hg-MP2400-Ab-2; GM-Tg-rg-MP2400-Ab-1/ GM-Tg-rg-MP2400-Ab-2;
GM-Tg-mg-MP2400-Ab-1/ GM-Tg-mg-MP2400-Ab-2; GM-Tg-cynog-MP2400-Ab-1/ GM-Tg-cynog-MP2400-Ab-2;
GM-Tg-felg-MP2400-Ab-1/ GM-Tg-felg-MP2400-Ab-2; GM-Tg-cang-MP2400-Ab-1/ GM-Tg-cang-MP2400-Ab-2;
GM-Tg-bovg-MP2400-Ab-1/ GM-Tg-bovg-MP2400-Ab-2; GM-Tg-equg-MP2400-Ab-1/ GM-Tg-equg-MP2400-Ab-2
Products NameAnti-NLRP6 monoclonal antibody
Formatmab
Target NameNLRP6
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-NLRP6 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species NLRP6/ AVR/ CLR11.4 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMLP001699human NLRP6 Lentivirus plasmid
    ORF Viral VectorvGMLP001699human NLRP6 Lentivirus particle


    Target information

    Target IDGM-MP2400
    Target NameNLRP6
    Gene ID171389,101613,171390,720741,483394,101087351,505101,100146460
    Gene Symbol and SynonymsAVR,CLR11.4,NALP6,NAVR,NAVR/AVR,NLRP6,Non-AVR,PAN3,PYPAF5
    Uniprot AccessionP59044,Q63035
    Uniprot Entry NameNLRP6_HUMAN,NLRP6_RAT
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000174885
    Target ClassificationN/A

    The target: NLRP6, gene name: NLRP6, also named as AVR, CLR11.4, NALP6, NAVR, NAVR/AVR, PAN3, PYPAF5. The protein encoded by this gene binds arginine-vasopressin and may be involved in the arginine-vasopressin-mediated regulation of renal salt-water balance. The encoded protein also mediates inflammatory responses in the colon to allow recovery from intestinal epithelial damage and protects against tumorigenesis and the development of colitis. Finally, this protein can increase activation of NF-kappa-B, activation of CASP1 through interaction with ASC, and cAMP accumulation. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Feb 2013].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.